Summary of Significant Accounting Policies (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2025

Dec. 31, 2024

Summary of Significant Accounting Policies [Abstract]

Schedule of Consolidated Statement of Changes in Stockholders’ Deficit

The effect of the contingent sponsor shares revision on the Common Stock amounts on each of the impacted financial statement line items within the Company’s unaudited condensed consolidated statement of changes in stockholders’ deficit for the periods presented below was as follows:

	As Previously Reported		Adjustments			As Revised
Balance at December 31, 2023		19,599,982		(1,000,000	)		18,599,982
Balance at March 31, 2024		19,599,982		(1,000,000	)		18,599,982
Balance at June 30, 2024		19,599,982		(1,000,000	)		18,599,982
Balance at September 30, 2024		19,730,982		(1,000,000	)		18,730,982

The effect of the financing of prepaid insurance revision on the accumulated deficit amounts on each of the impacted financial statement line items within the Company’s unaudited condensed consolidated statement of changes in stockholders’ deficit for the three and nine months ended September 30, 2024 was as follows:

	As Previously Reported			Adjustments			As Revised
Balance at December 31, 2023	$	(257,242	)	$	(14	)	$	(257,256	)
Balance at March 31, 2024		(264,877	)		(14	)		(264,891	)
Balance at June 30, 2024		(270,189	)		(14	)		(270,203	)
Balance at September 30, 2024		(277,529	)		(14	)		(277,543	)

The effect of the contingent sponsor shares revision on the Common Stock amounts on each of the impacted financial statement line items within the Company’s consolidated statement of stockholders’ deficit for the year ended December 31, 2023 was as follows:

	Year Ended December 31, 2023
	As  Previously Reported		Adjustments			As Revised
Merger, net of redemptions and transaction costs (Note 3)		4,115,874		(1,000,000	)		3,115,874
Balance at December 31, 2023		19,599,982		(1,000,000	)		18,599,982

The effect of the financing of prepaid insurance revision on the accumulated deficit amounts on each of the impacted financial statement line items within the Company’s consolidated statement of stockholders’ deficit for the year ended December 31, 2023 was as follows:

	Year Ended December 31, 2023
	As Previously Reported			Adjustments			As Revised
Net loss	$	(29,908	)	$	(14	)	$	(29,922	)
Balance at December 31, 2023	$	(257,242	)	$	(14	)	$	(257,256	)

Schedule of Consolidated Balance Sheet

The effect of the classification of prepaid insurance expense and accrued interest (related party) revisions on each of the impacted financial statement line items within the Company’s audited consolidated balance sheet as of December 31, 2024 was as follows:

	December 31, 2024
	As Previously Reported		Adjustments			As Revised
Prepaid expenses and other assets, current	$	1,375	$	(488	)	$	887
Total current assets		9,384		(488	)		8,896
Prepaid expenses and other assets		—		488			488
Accrued expenses		4,416		(703	)		3,713
Accrued interest (related party)		—		703			703

The effect of the financing of prepaid insurance revision on each of the impacted financial statement line items within the Company’s consolidated balance sheet as of December 31, 2023 was as follows:

	December 31, 2023
	As Previously Reported			Adjustments			As Revised
Prepaid expenses and other current assets	$	957		$	631		$	1,588
Total current assets		6,825			631			7,456
Total assets	$	7,640		$	631		$	8,271
Other current liabilities	$	—		$	645		$	645
Total current liabilities		6,640			645			7,285
Total liabilities		9,402			645			10,047
Accumulated deficit		(257,242	)		(14	)		(257,256	)
Total stockholders’ deficit		(1,762	)		(14	)		(1,776	)
Total liabilities and stockholders’ deficit	$	7,640		$	631		$	8,271

Schedule of Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss

The effect of the contingent sponsor shares and financing of prepaid insurance revisions on each of the impacted financial statement line items within the Company’s unaudited condensed consolidated statements of operations and comprehensive loss for the three and nine months ended September 30, 2024 was as follows:

	Nine Months Ended September 30, 2024
	As Previously Reported			Adjustments			As Revised
General and administrative	$	5,406		$	(25	)	$	5,381
Total costs and operating expenses		14,915			(25	)		14,890
Operating loss		(14,732	)		25			(14,707	)
Other income (expense), net		15			(25	)		(10	)
Total other income (expense), net		(1,445	)		(25	)		(1,470	)
Net loss per share attributable to common stockholders, basic and diluted	$	(1.03	)	$	(0.06	)	$	(1.09	)
Weighted-average Class A Common Stock outstanding, basic and diluted		19,605,482			(1,000,000	)		18,605,482

	Three Months Ended September 30, 2024
	As Previously Reported			Adjustments			As Revised
General and administrative	$	1,692		$	(2	)	$	1,690
Total costs and operating expenses		5,030			(2	)		5,028
Operating loss		(4,974	)		2			(4,972	)
Other income (expense), net		15			(2	)		13
Total other income (expense), net		(986	)		(2	)		(988	)
Net loss per share attributable to common stockholders, basic and diluted	$	(0.37	)	$	(0.02	)	$	(0.39	)
Weighted-average Class A Common Stock outstanding, basic and diluted		19,616,362			(1,000,000	)		18,616,362

The effect of the cumulative preferred dividends, contingent sponsor shares, and financing of prepaid insurance revisions on each of the impacted financial statement line items within the Company’s consolidated statement of operations and comprehensive loss for the year ended December 31, 2023 was as follows:

	Year Ended December 31, 2023
	As  Previously Reported			Adjustments			As Revised
General and administrative		7,276			(12	)		7,264
Total costs and operating expenses		18,687			(12	)		18,675
Operating loss		(18,371	)		12			(18,359	)
Other (expense) income		80			(26	)		54
Total other expense, net		(11,537	)		(26	)		(11,563	)
Net loss		(29,908	)		(14	)		(29,922	)
Cumulative preferred dividends		—			(1,349	)		(1,349	)
Net loss attributable to common stockholders, basic and diluted	$	(29,908	)	$	(1,363	)	$	(31,271	)
Net loss per share attributable to common stockholders, basic and diluted	$	(2.38	)	$	(0.16	)	$	(2.54	)
Weighted-average Class A Common Stock outstanding, basic and diluted		12,552,925			(257,534	)		12,295,391

Schedule of Condensed Consolidated Statement of Cash Flows

The effect of the financing of prepaid insurance revision on each of the impacted financial statement line items within the Company’s unaudited condensed consolidated statement of cash flows for the nine months ended September 30, 2024 was as follows:

	Nine Months Ended September 30, 2024
	As Previously Reported			Adjustments			As Revised
Amortization of prepaid insurance	$	-		$	809		$	809
Prepaid expenses and other current assets		657			(106	)		551
Net cash used in operating activities		(13,561	)		703			(12,858	)
Payments on insurance financing loans		-			(703	)		(703	)
Net cash provided by financing activities		15,284			(703	)		14,581
Supplemental disclosures of cash flow information:
Cash paid for interest	$	-		$	25		$	25
Non-cash investing and financing activities:
Financing of prepaid insurance	$	-		$	843		$	843

The effect of the financing of prepaid insurance revision on each of the impacted financial statement line items within the Company’s consolidated statements of cash flows for the year ended December 31, 2023 was as follows:

	Year Ended December 31, 2023
	As  Previously Reported			Adjustments			As Revised
Amortization of prepaid insurance	$	—		$	602		$	602
Prepaid expenses and other current assets		(828	)		(25	)		(853	)
Net cash used in operating activities		(17,668	)		577			(17,091	)
Payments on insurance financing loans		—			(563	)		(563	)
Net cash provided by financing activities		21,845			(563	)		21,282
Supplemental disclosures of cash flow information:
Cash paid for interest	$	—		$	26		$	26
Non-cash investing and financing activities:
Financing of prepaid insurance	$	—		$	1,115		$	1,115